What sources count as literature review citations for my residency paper?

To meet your supervising professor's rubric, both clinical practice guidelines and conference abstracts can absolutely count as distinct source categories for your literature review, but they carry very different weights in academic publishing. To safely satisfy the requirement of having three distinct types of sources alongside your primary research articles, clinical guidelines are your safest and most robust bet, while conference abstracts should be used with caution. In the context of an internal medicine manuscript, literature review sources are categorized by their clinical authority and peer-review status. Since you already have primary research articles (which are original, peer-reviewed data) and textbook chapters (which represent established, tertiary consensus), adding clinical guidelines gives you a highly respected third category of secondary literature that reflects current standards of care. The main nuance lies in how these different sources are perceived in a formal AMA-style bibliography and how they impact your paper's credibility. Clinical guidelines published by major medical societies are considered gold-standard secondary sources because they undergo rigorous systematic reviews before publication. On the other hand, conference abstracts are often viewed as preliminary data. While they are technically citable in AMA style, many journal editors and professors look at them skeptically because the full methodology hasn't yet undergone the full peer-review process. A common misconception among residents is that any indexed text counts equally, but relying too heavily on abstracts can weaken your literature review. However, if you use an abstract to highlight the very latest, cutting-edge trial that hasn't been fully published yet, it serves a great academic purpose. Let’s look at a hypothetical scenario to see how this plays out in your actual writing. Imagine you are writing your manuscript on new dual-therapy protocols for managing resistant hypertension. Your primary research articles provide the raw clinical trial data, and your textbook chapters establish the historical physiological background of the drug classes. To round out your three sources, you cite the latest joint national clinical guidelines to show how these drugs are currently recommended for clinic workflows. Then, to show you are on the absolute frontier of the field, you cite a conference abstract from last month's American Heart Association scientific sessions detailing an ongoing phase-three trial. This combination not only satisfies the three-source rubric easily but also demonstrates to your supervisor that you understand how to synthesize historical context, raw data, official recommendations, and emerging science. Ultimately, your exact selection depends on the specific focus of your manuscript and your supervisor's personal preferences. Since your deadline is three weeks away, I highly recommend prioritizing the clinical guidelines as your definitive third category because they are incredibly easy to cite in AMA style and carry immense academic authority. If you do decide to use a conference abstract, just ensure it is absolutely necessary for illustrating a gap in current research or a brand-new development, and perhaps shoot a quick email to your supervising professor to confirm they view abstracts as a standalone category under their specific rubric.